1. Home
  2. NVNI vs CVM Comparison

NVNI vs CVM Comparison

Compare NVNI & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNI
  • CVM
  • Stock Information
  • Founded
  • NVNI 2019
  • CVM 1983
  • Country
  • NVNI Brazil
  • CVM United States
  • Employees
  • NVNI N/A
  • CVM N/A
  • Industry
  • NVNI
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NVNI
  • CVM Health Care
  • Exchange
  • NVNI Nasdaq
  • CVM Nasdaq
  • Market Cap
  • NVNI 57.2M
  • CVM 63.3M
  • IPO Year
  • NVNI N/A
  • CVM 1987
  • Fundamental
  • Price
  • NVNI $4.13
  • CVM $8.91
  • Analyst Decision
  • NVNI
  • CVM
  • Analyst Count
  • NVNI 0
  • CVM 0
  • Target Price
  • NVNI N/A
  • CVM N/A
  • AVG Volume (30 Days)
  • NVNI 1.3M
  • CVM 82.9K
  • Earning Date
  • NVNI 09-30-2025
  • CVM 08-14-2025
  • Dividend Yield
  • NVNI N/A
  • CVM N/A
  • EPS Growth
  • NVNI N/A
  • CVM N/A
  • EPS
  • NVNI N/A
  • CVM N/A
  • Revenue
  • NVNI $31,250,627.00
  • CVM N/A
  • Revenue This Year
  • NVNI $12.05
  • CVM N/A
  • Revenue Next Year
  • NVNI $15.02
  • CVM N/A
  • P/E Ratio
  • NVNI N/A
  • CVM N/A
  • Revenue Growth
  • NVNI 1491.58
  • CVM N/A
  • 52 Week Low
  • NVNI $1.44
  • CVM $1.98
  • 52 Week High
  • NVNI $121.90
  • CVM $32.70
  • Technical
  • Relative Strength Index (RSI)
  • NVNI 71.42
  • CVM 44.54
  • Support Level
  • NVNI $2.96
  • CVM $9.37
  • Resistance Level
  • NVNI $4.94
  • CVM $10.24
  • Average True Range (ATR)
  • NVNI 0.51
  • CVM 0.69
  • MACD
  • NVNI 0.21
  • CVM -0.10
  • Stochastic Oscillator
  • NVNI 83.44
  • CVM 13.51

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: